The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study

Conley, BA; Staudt, L; Takebe, N; Wheeler, DA; Wang, LH; Cardenas, MF; Korchina, V; Zenklusen, JC; McShane, LM; Tricoli, JV; Williams, PM; Lubensky, I; O'Sullivan-Coyne, G; Kohn, E; Little, RF; White, J; Malik, S; Harris, LN; Mann, B; Weil, C; Tarnuzzer, R; Karlovich, C; Rodgers, B; Shankar, L; Jacobs, PM; Nolan, T; Berryman, SM; Gastier-Foster, J; Bowen, J; Leraas, K; Shen, H; Laird, PW; Esteller, M; Miller, V; Johnson, A; Edmondson, EF; Giordano, TJ; Kim, B; Ivy, SP

Ivy, SP (corresponding author), Natl Canc Inst, 9609 Med Ctr Dr Room 5W458, Bethesda, MD 20852 USA.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021; 113 (1): 27

Abstract

Background Tumor molecular profiling from patients experiencing exceptional responses to systemic therapy may provide insights into cancer biology and......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索